|
Cayman Islands
|
| |
3826
|
| |
Not Applicable
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification Number) |
|
|
Jonathan B. Stone, Esq.
Paloma Wang, Esq. Skadden, Arps, Slate, Meagher & Flom LLP 42/F, Edinburgh Tower, The Landmark 15 Queen’s Road Central Hong Kong Tel: +852 3740-4700 |
| |
Peter X. Huang, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP 30/F, China World Office 2 No. 1, Jian Guo Men Wai Avenue Beijing 100004, P.R. China Tel: +86 10-6535-5500 |
| |
Jesse Sheley
Joseph Raymond Casey Ram Narayan Louis Rabinowitz Kirkland & Ellis International LLP 26th Floor, Gloucester Tower The Landmark 15 Queen’s Road Central Hong Kong Tel: +852-3761-3300 |
| |
Steve Lin
Kirkland & Ellis International LLP 29th Floor, China World Office 2 No.1 Jian Guo Men Wai Avenue Beijing 100004, P.R. China Tel: +86 10-5737-9300 |
|
| | | | Sincerely, | |
| | | |
Cheng Yin Pan
Chief Executive Officer and Director |
|
| | |
PAGES
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 9 | | | |
| | | | 27 | | | |
| | | | 49 | | | |
| | | | 50 | | | |
| | | | 60 | | | |
| | | | 62 | | | |
| | | | 64 | | | |
| | | | 66 | | | |
| | | | 129 | | | |
| | | | 135 | | | |
| | | | 153 | | | |
| | | | 157 | | | |
| | | | 191 | | | |
| | | | 192 | | | |
| | | | 193 | | | |
| | | | 195 | | | |
| | | | 210 | | | |
| | | | 214 | | | |
| | | | 225 | | | |
| | | | 266 | | | |
| | | | 287 | | | |
| | | | 302 | | | |
| | | | 312 | | | |
| | | | 323 | | | |
| | | | 329 | | | |
| | | | 337 | | | |
| | | | 339 | | | |
| | | | 342 | | | |
| | | | 345 | | | |
| | | | 346 | | | |
| | | | 347 | | | |
| | | | 348 | | | |
| | | | 349 | | |
| | |
PAGES
|
| |||
| | | | 350 | | | |
| | | | 351 | | | |
| | | | 352 | | | |
EXPERTS | | | | | 353 | | |
| | | | F-1 | | | |
ANNEXES | | | |||||
Annex A:
Business Combination Agreement (filed as Exhibit 2.1 to this proxy statement/prospectus)
|
| | | | | | |
Annex B:
Amended and Restated Memorandum and Articles of Association of PubCo (filed as Exhibit 3.1 to this proxy statement/prospectus)
|
| | | | | | |
| | |
Share Ownership and Voting Power in PubCo(1)(2)(3)(4)
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | |
Assuming No Redemptions (Shares)
|
| |
Assuming Maximum Redemptions (Shares)
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | |
Number of
Class A Ordinary Shares |
| |
Share
Ownership % |
| |
Voting
Power % |
| |
Number of
Class B Ordinary Shares |
| |
Share
Ownership % |
| |
Voting
Power % |
| |
Number of
Class A Ordinary Shares |
| |
Share
Ownership % |
| |
Voting
Power % |
| |
Number of
Class B Ordinary Shares |
| |
Share
Ownership % |
| |
Voting
Power % |
| ||||||||||||||||||||||||||||||||||||
Prenetics Shareholders
|
| | | | 71,784,095 | | | | | | 51.51% | | | | | | 22.17% | | | | | | 9,711,166 | | | | | | 6.97% | | | | | | 59.97% | | | | | | 71,784,095 | | | | | | 62.23% | | | | | | 23.94% | | | | | | 9,711,166 | | | | | | 8.42% | | | | | | 64.76% | | |
Artisan Public Shareholders(6)
|
| | | | 36,934,235 | | | | | | 26.51% | | | | | | 11.40% | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,352,497 | | | | | | 8.97% | | | | | | 3.45% | | | | | | — | | | | | | — | | | | | | — | | |
Sponsor and certain Artisan directors(5)(7)
|
| | | | 7,033,558 | | | | | | 5.05% | | | | | | 2.17% | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,033,558 | | | | | | 6.10% | | | | | | 2.35% | | | | | | — | | | | | | — | | | | | | — | | |
PIPE Investors(8)
|
| | | | 6,530,438 | | | | | | 4.69% | | | | | | 2.02% | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,768,126 | | | | | | 6.73% | | | | | | 2.59% | | | | | | — | | | | | | — | | | | | | — | | |
Forward Purchase Investors(5)(9)
|
| | | | 7,346,743 | | | | | | 5.27% | | | | | | 2.27% | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,739,142 | | | | | | 7.57% | | | | | | 2.91% | | | | | | — | | | | | | — | | | | | | — | | |
Pro forma Combined Company Ordinary Shares
|
| | |
|
129,629,069
|
| | | |
|
93.03%
|
| | | |
|
40.03%
|
| | | |
|
9,711,166
|
| | | |
|
6.97%
|
| | | |
|
59.97%
|
| | | |
|
105,677,418
|
| | | |
|
91.58%
|
| | | |
|
35.24%
|
| | | |
|
9,711,166
|
| | | |
|
8.42%
|
| | | |
|
64.76%
|
| |
Percentage of Maximum Redemption(1)
|
| |
0.0%
|
| |
25.0%
|
| |
50.0%
|
| |
75.0%
|
| |
91.6%
|
| |
100.0%
|
| ||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(resulting in
maximum exchange ratio) |
| | | | | | | |||
Implied Price Per Share | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||
Percentage of Public Shares Redeemed
|
| | | | 0.0% | | | | | | 19.1% | | | | | | 38.2% | | | | | | 57.3% | | | | | | 70.0% | | | | | | 76.4% | | |
Percentage of Public Shares Not Redeemed
|
| | | | 100.0% | | | | | | 80.9% | | | | | | 61.8% | | | | | | 42.7% | | | | | | 30.0% | | | | | | 23.6% | | |
Trust Account Size (in millions)
|
| | | $ | 339.3 | | | | | $ | 274.5 | | | | | $ | 209.7 | | | | | $ | 144.8 | | | | | $ | 101.8 | | | | | $ | 80.0 | | |
Assumed Price Per Artisan Public Share at Closing of SPAC Merger
|
| | | $ | 10.00 | | | | | $ | 10.00 | | | | | $ | 10.00 | | | | | $ | 10.00 | | | | | $ | 10.00 | | | | | $ | 10.00 | | |
Remaining Public Shares (in millions)
|
| | | | 33.93 | | | | | | 27.45 | | | | | | 20.97 | | | | | | 14.48 | | | | | | 10.18 | | | | | | 8.00 | | |
Additional Artisan Public Shares Available to Non-Redeeming Holders (in
millions) |
| | | | 3.00 | | | | | | 3.00 | | | | | | 3.00 | | | | | | 3.00 | | | | | | 3.00 | | | | | | 2.36 | | |
Class A Exchange Ratio
|
| | | | 1.09 | | | | | | 1.11 | | | | | | 1.14 | | | | | | 1.21 | | | | | | 1.29 | | | | | | 1.29 | | |
Implied Price Per Artisan Public Share
|
| | | $ | 9.19 | | | | | $ | 9.01 | | | | | $ | 8.75 | | | | | $ | 8.28 | | | | | $ | 7.72 | | | | | $ | 7.72 | | |
Implied Initial Merger Consideration Per Artisan Public Share
|
| | | $ | 10.88 | | | | | $ | 11.09 | | | | | $ | 11.43 | | | | | $ | 12.07 | | | | | $ | 12.95 | | | | | $ | 12.95 | | |
| | |
As of December 31, 2021
|
| |||
Balance Sheet Data: | | | | | | | |
Cash
|
| | | $ | 102,212 | | |
Investments held in trust account
|
| | | $ | 339,380,717 | | |
Total assets
|
| | | $ | 340,178,214 | | |
Warrant liabilities
|
| | | $ | 12,248,790 | | |
Derivative liability – forward purchase agreement
|
| | | $ | 484,643 | | |
Deferred underwriting fee payable
|
| | | $ | 11,876,982 | | |
Total liabilities
|
| | | $ | 27,888,846 | | |
Class A ordinary shares subject to possible redemption
|
| | | $ | 339,342,350 | | |
Total shareholders’ deficit
|
| | | $ | (27,052,982) | | |
| | |
For the Period
From February 2, 2021 (Inception) Through December 31, 2021 |
| |||
Statement of Operations Data: | | | | | | | |
Loss from operations
|
| | | $ | (3,943,227) | | |
Expensed offering costs
|
| | | | (534,056) | | |
Unrealized gain on investments held in trust account
|
| | | | 34,150 | | |
Change in fair value of derivative liability – forward purchase agreement
|
| | | | (874,285) | | |
Change in fair value of warrant liabilities
|
| | | | 2,005,780 | | |
Dividend income on investments held in Trust Account
|
| | | | 4,217 | | |
Net loss
|
| | | $ | (3,307,421) | | |
Basic and diluted weighted average shares outstanding, Class A ordinary shares
|
| | | | 23,119,071 | | |
Basic and diluted net loss per ordinary share, Class A ordinary shares
|
| | | $ | (0.10) | | |
Basic and diluted weighted average shares outstanding, Class B ordinary shares
|
| | | | 9,597,539 | | |
Basic and diluted net loss per ordinary share, Class B ordinary shares
|
| | | $ | (0.10) | | |
| | |
For the Period
From February 2, 2021 (Inception) Through December 31, 2021 |
| |||
Statement of Cash Flows Data: | | | | | | | |
Net cash used in operating activities
|
| | | $ | (1,372,731) | | |
Net cash used in investing activities
|
| | | $ | (339,342,350) | | |
Net cash provided by financing activities
|
| | | $ | 340,817,293 | | |
| | |
For the Years Ended
December 31, |
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
Selected Statement of Profit or Loss and Other Comprehensive Income Data:
|
| | | | | | | | | | | | | | | | | | |
Revenue | | | | $ | 275,852,753 | | | | | $ | 65,179,515 | | | | | $ | 9,233,089 | | |
Operating expenses
|
| | | | (286,070,281) | | | | | | (66,174,641) | | | | | | (30,036,374) | | |
Loss from operations
|
| | | | (10,217,528) | | | | | | (995,126) | | | | | | (20,803,285) | | |
Finance costs
|
| | | | (5,238,030) | | | | | | (59,567) | | | | | | (69,390) | | |
Fair value loss on convertible securities
|
| | | | (29,054,669) | | | | | | (2,846,750) | | | | | | — | | |
Fair value loss on preference shares liabilities
|
| | | | (125,398,798) | | | | | | — | | | | | | — | | |
Fair value loss on financial assets at fair value through profit or loss
|
| | | | (94,000) | | | | | | — | | | | | | — | | |
Write-off on amount due from a shareholder
|
| | | | (106,179) | | | | | | — | | | | | | — | | |
Gain on bargain purchase
|
| | | | 117,238 | | | | | | — | | | | | | — | | |
Loss on disposal of a subsidiary
|
| | | | (292,132) | | | | | | — | | | | | | — | | |
Loss before taxation
|
| | | | (170,284,098) | | | | | | (3,901,443) | | | | | | (20,872,675) | | |
Income tax (expense)/credit
|
| | | | (3,732,744) | | | | | | 1,937,558 | | | | | | 677,474 | | |
Loss for the year
|
| | | | (174,016,842) | | | | | | (1,963,885) | | | | | | (20,195,201) | | |
Loss attributable to: | | | | | | | | | | | | | | | | | | | |
Equity shareholders of Prenetics
|
| | | | (174,009,273) | | | | | | (1,939,689) | | | | | | (20,141,991) | | |
Non-controlling interests
|
| | | | (7,569) | | | | | | (24,196) | | | | | | (53,210) | | |
Loss for the year
|
| | | | (174,016,842) | | | | | | (1,963,885) | | | | | | (20,195,201) | | |
Weighted average number of ordinary shares for the purpose of basic loss
per share |
| | | | 14,596,997 | | | | | | 13,176,752 | | | | | | 12,891,569 | | |
Weighted average number of ordinary shares for the purpose of diluted loss per share
|
| | | | 14,596,997 | | | | | | 13,176,752 | | | | | | 12,891,569 | | |
Basic loss per share
|
| | | $ | (11.92) | | | | | $ | (0.15) | | | | | $ | (1.56) | | |
Diluted loss per share
|
| | | $ | (11.92) | | | | | $ | (0.15) | | | | | $ | (1.56) | | |
| | |
As of December 31,
|
| ||||||||||||
| | |
2021
|
| |
2020
|
| | ||||||||
Selected Statement of Financial Position Data: | | | | | | | | | | | | | | | | |
Assets | | | | | | | | | | | | | | | | |
Non-current assets
|
| | | $ | 41,614,789 | | | | | | 34,926,561 | | | | ||
Current assets
|
| | | | 106,892,532 | | | | | | 43,956,750 | | | | ||
Total assets
|
| | | | 148,507,321 | | | | | | 78,883,311 | | | | ||
Liabilities | | | | | | | | | | | | | | | | |
Preferred shares classified as non-current liabilities
|
| | | | 486,404,770 | | | | | | — | | | | ||
Other non-current liabilities
|
| | | | 4,259,730 | | | | | | 804,574 | | | | ||
Current liabilities
|
| | | | 58,737,734 | | | | | | 47,071,730 | | | | ||
Total liabilities
|
| | | | 549,402,234 | | | | | | 47,876,304 | | | | ||
Equity | | | | | | | | | | | | | | | | |
Total (equity deficiency)/equity attributable to equity shareholders of Prenetics
|
| | | | (400,809,938) | | | | | | 31,084,413 | | | | ||
Non-controlling interests
|
| | | | (84,975) | | | | | | (77,406) | | | | ||
Total (equity deficiency)/equity
|
| | | | (400,894,913) | | | | | | 31,007,007 | | | | ||
Total equity and liabilities
|
| | | | 148,507,321 | | | | | | 78,883,311 | | | |
| | |
For the year ended December 31, 2021
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| | |
Prenetics
$ |
| |
Prenetics HK
$ |
| |
WFOE
$ |
| |
VIE
$ |
| |
Other
Subsidiaries $ |
| |
Prenetics
adjustment $ |
| |
Inter-company
Elimination $ |
| |
Other
Adjustment (note(e)) $ |
| |
Prenetics Group
$ |
| |||||||||||||||||||||||||||
Revenue
|
| | | | — | | | | | | 125,462,376 | | | | | | — | | | | | | — | | | | | | 155,052,156 | | | | | | — | | | | | | (581,538) | | | | | | (4,080,241) | | | | | | 275,852,753 | | |
Direct costs
|
| | | | — | | | | | | (58,367,297) | | | | | | — | | | | | | — | | | | | | (114,528,559) | | | | | | — | | | | | | 616,778 | | | | | | 2,557,536 | | | | | | (169,721,542) | | |
Gross profit
|
| | | | — | | | | | | 67,095,079 | | | | | | — | | | | | | — | | | | | | 40,523,597 | | | | | | — | | | | | | 35,240 | | | | | | (1,522,705) | | | | | | 106,131,211 | | |
Other income and other net
(losses)/gains |
| | | | — | | | | | | (850,200) | | | | | | 5,498 | | | | | | 92 | | | | | | 442,139 | | | | | | — | | | | | | 40,501 | | | | | | 500,918 | | | | | | 138,948 | | |
Selling and distribution expenses
|
| | | | — | | | | | | (13,697,000) | | | | | | — | | | | | | — | | | | | | (8,235,322) | | | | | | — | | | | | | — | | | | | | — | | | | | | (21,932,322) | | |
Research and development expenses
|
| | | | — | | | | | | (8,593,950) | | | | | | — | | | | | | — | | | | | | (1,970,002) | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,563,952) | | |
Administrative and other operating expenses
|
| | | | — | | | | | | (56,359,375) | | | | | | (17,478) | | | | | | (417) | | | | | | (25,655,932) | | | | | | — | | | | | | (4,556) | | | | | | (1,953,655) | | | | | | (83,991,413) | | |
(Loss)/profit from operations
|
| | | | — | | | | | | (12,405,446) | | | | | | (11,980) | | | | | | (325) | | | | | | 5,104,480 | | | | | | — | | | | | | 71,185 | | | | | | (2,975,442) | | | | | | (10,217,528) | | |
Finance costs
|
| | | | (5,009,847) | | | | | | (109,373) | | | | | | — | | | | | | — | | | | | | (178,103) | | | | | | — | | | | | | (440) | | | | | | 59,733 | | | | | | (5,238,030) | | |
Fair value loss on convertible securities
|
| | | | — | | | | | | (29,673,603) | | | | | | — | | | | | | — | | | | | | — | | | | | | 618,934 | | | | | | — | | | | | | — | | | | | | (29,054,669) | | |
Fair value loss on preference shares liabilities
|
| | | | (125,398,798) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (125,398,798) | | |
Fair value loss on financial derivatives
|
| | | | — | | | | | | (9,750,930) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 9,750,930 | | | | | | — | | | | | | — | | |
Fair value loss on financial assets at fair value through profit or loss
|
| | | | — | | | | | | (94,000) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (94,000) | | |
Write-off on amount due from a shareholder
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (106,179) | | | | | | — | | | | | | — | | | | | | — | | | | | | (106,179) | | |
Gain on bargain purchase
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 117,238 | | | | | | 117,238 | | |
Loss on disposal of a subsidiary
|
| | | | — | | | | | | (292,132) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (292,132) | | |
(Loss)/profit before taxation
|
| | | | (130,408,645) | | | | | | (52,325,484) | | | | | | (11,980) | | | | | | (325) | | | | | | 4,820,198 | | | | | | 618,934 | | | | | | 9,821,675 | | | | | | (2,798,471) | | | | | | (170,284,098) | | |
Income tax (expense)/credit
|
| | | | — | | | | | | (3,709,524) | | | | | | — | | | | | | — | | | | | | (28,319) | | | | | | — | | | | | | — | | | | | | 5,099 | | | | | | (3,732,744) | | |
(Loss)/profit for the year
|
| | | | (130,408,645) | | | | | | (56,035,008) | | | | | | (11,980) | | | | | | (325) | | | | | | 4,791,879 | | | | | | 618,934 | | | | | | 9,821,675 | | | | | | (2,793,372) | | | | | | (174,016,842) | | |
Other comprehensive income for the year
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Item that may be reclassified subsequently
to profit or loss: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Exchange differences on translation of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
– financial statements of subsidiaries and a
joint venture outside Hong Kong |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 260,112 | | | | | | 260,112 | | |
Total comprehensive income for the year
|
| | | | (130,408,645) | | | | | | (56,035,008) | | | | | | (11,980) | | | | | | (325) | | | | | | 4,791,879 | | | | | | 618,934 | | | | | | 9,821,675 | | | | | | (2,533,260) | | | | | | (173,756,730) | | |
| | |
December 31, 2021
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | |
Prenetics
$ |
| |
Prenetics HK
$ |
| |
WFOE
$ |
| |
VIE
$ |
| |
Other
Subsidiaries $ |
| |
Prenetics
adjustment $ |
| |
WFOE
adjustment |
| |
VIE
adjustment |
| |
Inter-company
Elimination $ |
| |
Other
Adjustment (note(e)) $ |
| |
Prenetics
Group $ |
| |||||||||||||||||||||||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Property, plant and
equipment |
| | | | — | | | | | | 8,059,326 | | | | | | — | | | | | | — | | | | | | 4,973,519 | | | | | | — |